These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 8153085)
1. Effect of the choline acetyltransferase inhibitor (2-benzoylethyl)-trimethylammonium iodide (BETA) on human placental prostaglandin release and phospholipase A2 activity. Chen YS; King RG; Rook TJ; Brennecke SP Placenta; 1993; 14(6):627-40. PubMed ID: 8153085 [TBL] [Abstract][Full Text] [Related]
2. Effect of (2-benzoylethyl)trimethylammonium and vesamicol on acetylcholine and prostaglandin release from human placental explants. Chen YS; Brennecke SP; Rook TJ; King RG Reprod Fertil Dev; 1991; 3(4):467-74. PubMed ID: 1957036 [TBL] [Abstract][Full Text] [Related]
3. Ovine allantoic fluid inhibition of prostaglandin synthesis in cotyledonary microsomes. Rice GE; Wong MH; Ralph MM; Thorburn GD J Endocrinol; 1987 Aug; 114(2):295-300. PubMed ID: 3477611 [TBL] [Abstract][Full Text] [Related]
4. The effect of choline acetyltransferase inhibition on acetylcholine synthesis and release in term human placenta. Leventer SM; Rowell PP; Clark MJ J Pharmacol Exp Ther; 1982 Aug; 222(2):301-5. PubMed ID: 7097550 [TBL] [Abstract][Full Text] [Related]
5. Reduction of human recombinant type II phospholipase A2 and prostaglandin F2 alpha release by microtubule depolymerizing agents. Munns MJ; King RG; Rice GE Clin Exp Pharmacol Physiol; 1999 Mar; 26(3):230-5. PubMed ID: 10081619 [TBL] [Abstract][Full Text] [Related]
6. Release of acetylcholine from fragments of human term placenta and effects of the choline acetyltransferase inhibitor (2-benzoylethyl)trimethylammonium iodide. Welsch F; Stedman DB; Wenger WC Res Commun Chem Pathol Pharmacol; 1983 Aug; 41(2):179-96. PubMed ID: 6635315 [TBL] [Abstract][Full Text] [Related]
7. Contribution of type II PLA2 to prostaglandin formation: a study using a type II PLA2 specific inhibitor SB 203347. Munns MJ; King RG; Rice GE Prostaglandins Other Lipid Mediat; 1999 Jul; 57(5-6):361-70. PubMed ID: 10480490 [TBL] [Abstract][Full Text] [Related]
8. Stimulative effect of cadmium on prostaglandin E2 production in primary mouse osteoblastic cells. Miyahara T; Tonoyama H; Watanabe M; Okajima A; Miyajima S; Sakuma T; Nemoto N; Takayama K Calcif Tissue Int; 2001 Mar; 68(3):185-91. PubMed ID: 11351503 [TBL] [Abstract][Full Text] [Related]
9. Interleukin-4 inhibits prostaglandin G/H synthase-2 and cytosolic phospholipase A2 induction in neonatal mouse parietal bone cultures. Kawaguchi H; Nemoto K; Raisz LG; Harrison JR; Voznesensky OS; Alander CB; Pilbeam CC J Bone Miner Res; 1996 Mar; 11(3):358-66. PubMed ID: 8852946 [TBL] [Abstract][Full Text] [Related]
10. Effect of bacterial endotoxin on the in vitro release of Type II phospholipase-A2 and prostaglandin E2 from human placenta. Farrugia W; Nicholls L; Rice GE J Endocrinol; 1999 Feb; 160(2):291-6. PubMed ID: 9924199 [TBL] [Abstract][Full Text] [Related]
11. Effects of lipopolysaccharide on human placental prostaglandin F2 alpha production in vitro. Gu W; Rice GE; Brennecke SP Prostaglandins Leukot Essent Fatty Acids; 1994 Jun; 50(6):311-5. PubMed ID: 7938082 [TBL] [Abstract][Full Text] [Related]
12. Regulation of prostaglandin F2alpha by the specific inhibition of secretory type II phospholipase A2: implications for the management of premature labour. Munns MJ; King RG; Rice GE Gynecol Obstet Invest; 1999; 48(1):22-7. PubMed ID: 10394087 [TBL] [Abstract][Full Text] [Related]
13. Antisense oligonucleotide inhibition of type II phospholipase A2 expression, release and activity in vitro. Lappas M; Munns MJ; King RG; Rice GE Placenta; 2001 May; 22(5):418-24. PubMed ID: 11373152 [TBL] [Abstract][Full Text] [Related]
14. Effects of dexamethasone and sulfasalazine on prostaglandin E2 output by human placental cells in vitro. Mirazi N; Alfaidy N; Martin R; Challis JR J Soc Gynecol Investig; 2004 Jan; 11(1):22-6. PubMed ID: 14706679 [TBL] [Abstract][Full Text] [Related]
15. Interleukin-1 beta induces cytosolic phospholipase A2 and prostaglandin H synthase in rheumatoid synovial fibroblasts. Evidence for their roles in the production of prostaglandin E2. Hulkower KI; Wertheimer SJ; Levin W; Coffey JW; Anderson CM; Chen T; DeWitt DL; Crowl RM; Hope WC; Morgan DW Arthritis Rheum; 1994 May; 37(5):653-61. PubMed ID: 8185692 [TBL] [Abstract][Full Text] [Related]
16. Dose-related effect of IGF-I on placental prostanoid release. Siler-Khodr TM; Forman J; Sorem KA Prostaglandins; 1995 Jan; 49(1):1-14. PubMed ID: 7792387 [TBL] [Abstract][Full Text] [Related]
17. 1(2-benzoylethyl)pyridinium chloride: a new potent and selective inhibitor of bovine brain and human placental choline acetyltransferase. Choudhuri MS; Chaturvedi AK Brain Res Bull; 1991 Jun; 26(6):845-50. PubMed ID: 1933404 [TBL] [Abstract][Full Text] [Related]
18. Control of oxytocin secretion by ovine corpora lutea: effects of arachidonic acid, phospholipases, and prostaglandins. Hirst JJ; Rice GE; Jenkin G; Thorburn GD Endocrinology; 1988 Mar; 122(3):774-81. PubMed ID: 3125041 [TBL] [Abstract][Full Text] [Related]
19. Cellular mechanisms mediating the stimulation of ovine endometrial secretion of prostaglandin F2 alpha in response to oxytocin: role of phospholipase A2. Lee JS; Silvia WJ J Endocrinol; 1994 Jun; 141(3):491-6. PubMed ID: 8071648 [TBL] [Abstract][Full Text] [Related]
20. Prostaglandin E2 in human placenta: its vascular effects and activation of prostaglandin E2 formation by nicotine and cotinine. Rama Sastry BV; Hemontolor ME; Olenick M Pharmacology; 1999 Feb; 58(2):70-86. PubMed ID: 9873232 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]